Clostridioides difficile Infection (CDI)Clostridioides difficile Infection (CDI)
Clostridioides difficile Infection (CDI)
Clostridioides difficile Infection (CDI)
有病率: 500,000 infections/year in the US; 29,000 deaths
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'gutcited.com';
const params = 'condition\u003Dclostridioides\u002Ddifficile';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
Evidence-Ranked Ingredients
| 成分 | グレード | 研究数 | 効果の方向 | |
|---|---|---|---|---|
| Saccharomyces boulardii | B | 6 | Positive | 詳細を見る → |
About
A toxin-mediated colonic infection caused by C. difficile, typically following antibiotic-induced gut dysbiosis. Toxins A and B cause mucosal inflammation, fluid secretion, and pseudomembrane formation. Recurrence rate is 20-30% after first episode, rising to 40-65% after multiple episodes.
Common Symptoms
Watery diarrhea (>=3/day)
Abdominal pain
Fever
Leukocytosis
Pseudomembranous colitis in severe cases
Risk Factors
- Recent antibiotic use
- Hospitalization
- Age >65
- PPI use
- Immunosuppression
- Prior CDI episode
- IBD
Frequently Asked Questions
What supplements may help with Clostridioides difficile Infection (CDI)?
Based on peer-reviewed research, supplements with the strongest evidence for Clostridioides difficile Infection (CDI) include Saccharomyces boulardii. These have earned Grade A or B ratings from our analysis of clinical studies. Always consult your healthcare provider before starting any supplement.
How is the evidence for Clostridioides difficile Infection (CDI) supplements graded?
We grade supplements on an A-F scale based on clinical study quality, consistency of results, sample sizes, and study design. Grade A indicates strong evidence from multiple clinical trials, while Grade D indicates preliminary evidence requiring further research.
How many studies on Clostridioides difficile Infection (CDI) supplements have been reviewed?
Our evidence grades for Clostridioides difficile Infection (CDI) are based on a total of 6 peer-reviewed studies across 1 ingredients. Studies are sourced from PubMed and include randomized controlled trials, meta-analyses, and other clinical research.
What are common symptoms of Clostridioides difficile Infection (CDI)?
Common symptoms associated with Clostridioides difficile Infection (CDI) include Watery diarrhea (>=3/day), Abdominal pain, Fever, Leukocytosis, Pseudomembranous colitis in severe cases. If you are experiencing these symptoms, consult a healthcare professional for proper diagnosis and treatment options.
Related Conditions
共通の研究済み成分を持つ症状
FDAに関する免責事項: これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。